NIH developed a special committee to assess Sabin’s vaccine.
In 1958, the NIH developed a special committee in the Division of Biologics Controls to assess Sabin’s live oral polio vaccine (OPV). Drs. Kirschstein, Murray, Van Hoosier, and Baron involved; Lab Technician George Rusten was as wellStandards to assess live oral polio vaccines. The committee was charged with testing virus strains that had been approved for use in manufacturing the oral vaccine. Researchers around the world began studies of the effectiveness and safety of Sabin’s oral polio vaccine. Dr. Kirschstein, and Dr. Samuel Baron led the committee. Dr. Murray,, Dr. Gerald Van Hoosier, Dr. Samuel Baron, and Lab Technician George Rusten were also involved in polio safety testing.
